Rs.9.17 lacs profit at HPC Biosciences in HY30.9.2019
HPC Biosciences announced its financial results for the HY1 of FY19-20 marking a fall in revenue and profit margins as compared to a year ago period.
Company : Indo Us Bio-Tech Ltd
HPC Biosciences declared its financial result for the period ended 30.09.2019 showing a depreciation of Rs.12.05 lacs in total HY1 PAT against the same in previous year"s corresponding period.
Below are the HY1 financials at HPC Biosciences in FY19-20
1. Total revenue was Rs.45.37 lacs in the current half year as compared to Rs.76.40 lacs in previous year same period.2. Net profit for the half year was Rs.9.17 lacs as against Rs.21.22 lacs in previous year corresponding period.By the end of financial result, FY2018-19 at HPC Biosciences, revenue was Rs.1.68 crore and PAT was Rs.55.42 lacs.
\n | Current Year Upto | \nPrevious Year Upto | \nPrevious Year | \n
---|---|---|---|
\n | 30/9/2019 | \n30/9/2018 | \n2018-2019 | \n
Income Statement | \n|||
Revenue | \n39.46 | \n70.50 | \n160.02 | \n
Other Income | \n5.91 | \n5.90 | \n8.95 | \n
Total Income | \n45.37 | \n76.4 | \n168.97 | \n
Expenditure | \n5.72 | \n13.08 | \n39.65 | \n
Finance Cost | \n0.00 | \n0.00 | \n0.00 | \n
PBDT | \n39.65 | \n63.32 | \n129.32 | \n
Depreciation | \n30.48 | \n42.10 | \n71.60 | \n
PBT | \n9.17 | \n21.22 | \n57.72 | \n
Tax | \n0.00 | \n0.00 | \n2.30 | \n
Net Profit | \n9.17 | \n21.22 | \n55.42 | \n
Equity | \n1596.00 | \n1596.00 | \n1596.00 | \n
EPS | \n0.00 | \n0.00 | \n0.00 | \n
Recent Stories
- WINNERS